| 國家衛生研究院 |
2014-05 |
Lung cancer risk in females due to exposures to PM2.5 in Taiwan
|
Chiang, PH;Chen, CW;Hsieh, DPH;Chan, TC;Chiang, HC;Wen, CP |
| 臺大學術典藏 |
2018-09-10T08:32:24Z |
Lung cancer risk in relation to traffic-related nano/ultrafine particle-bound PAHs exposure: A preliminary probabilistic assessment
|
Liao, C.-M.;Chio, C.-P.;Chen, W.-Y.;Ju, Y.-R.;Li, W.-H.;Cheng, Y.-H.;Liao, V.H.C.;Chen, S.-C.;Ling, M.-P.; Liao, C.-M.; Chio, C.-P.; Chen, W.-Y.; Ju, Y.-R.; Li, W.-H.; Cheng, Y.-H.; Liao, V.H.C.; Chen, S.-C.; Ling, M.-P.; Liao, Chung-Min; CHIA-PIN CHIO; VIVIAN LIAO; Chio, Chia-Pin; Chen, Wei-Yu; Jua, Yun-Ru; Li, Wen-Hsuan; Cheng, Yi-Hsien; Vivian Liao, Hsiu-Chuan; Chen, Szu-Chieh; Ling, Min-Pei |
| 臺大學術典藏 |
2022-03-25T07:13:23Z |
Lung cancer risk in relation to traffic-related nano/ultrafine particle-bound PAHs exposure: A preliminary probabilistic assessment
|
Liao C.-M.; CHIA-PIN CHIO; Chen W.-Y.; Ju Y.-R.; Li W.-H.; Cheng Y.-H.; Liao V.H.C.; Chen S.-C.; Ling M.-P. |
| 中山醫學大學 |
2011-06 |
Lung cancer risk in relation to traffic-related nano/ultrafine particle-bound PAHs exposure: a preliminary probabilistic assessment.
|
Liao CM;Chio CP;Chen WY;Ju YR;Li WH;Cheng YH;Liao VH;Chen SC;Ling MP |
| 國立臺灣大學 |
2011 |
Lung cancer risk in relation to traffic-related nano/ultrafine particle-bound PAHs exposure: A preliminary probabilistic assessment.
|
Liao, Chung-Min; Chio, Chia-Pin; Chen, Wei-Yu; Jua, Yun-Ru; Li, Wen-Hsuan; Cheng, Yi-Hsien; Vivian Liao, Hsiu-Chuan; Chen, Szu-Chieh; Ling, Min-Pei |
| 國立臺灣海洋大學 |
2011-03 |
Lung cancer risk in relation to traffic-related nano/ultrafine particle-bound polycyclic aromatic hydrocarbons exposure: A probabilistic assessment
|
Min-Pei Ling; Chia-Pin Chio; Chung-Min Liao; Wei-Yu Chen; Yun-Ru Ju; Wen-Hsuan Li; Yi-Hsien Cheng; Vivian Hsiu-Chuan Liao; Szu-Chieh Chen |
| 中國醫藥大學 |
2011-03 |
Lung cancer risk in relation to traffic-related nano/ultrafine particle-bound polycyclic aromatic hydrocarbons exposure: A probabilistic assessment
|
廖中明(Chung-Min Liao)*;邱嘉斌(Chia-Pin Chio);陳韋妤(Wei-Yu Chen);朱韻如(Yun-Ru Ju);李文軒(Wen-Hsuan Li);鄭亦奾(Yi-Hsien Cheng);廖秀娟(Vivian Hsiu-Chuan Liao);陳詩潔(Szu-Chieh Chen);凌明沛(Min-Pei Ling) |
| 中國醫藥大學 |
2015-05-17 |
Lung Cancer Screening Using Low Dose Computed Tomography
|
余養豪(Yang-Hao Yu);林延淞(Yan-Song Lin);吳重亭(Chung-Ting Wu);沈偉誌(Wei-Chih Shen);余養豪(Yang-Hao Yu) |
| 中山醫學大學 |
2016 |
Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan
|
Chen, Chen C.-Y.;Chen, Chen C.-H.;Shen, T.-C.;Cheng, W.-C.;Hsu, C.-N.;Liao, C.-H.;Chen, Chen C.-Y.;Hsia, T.-C.;Liao, W.-C.;Tu, C.-Y.;Shih, C.-M.;Hsu, W.-H. |
| 國立成功大學 |
2020 |
Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: An interrupted time series study
|
Hsu, J.C.;Wei, C.-F.;Yang, S.-C.;Lin, P.-C.;Lee, Y.-C.;Lu, C.Y. |
| 中國醫藥大學 |
2009-09 |
Lung cancer susceptibility and genetic polymorphism of DNA repair gene XRCC4 in Taiwan
|
許南榮(Nan-Yung Hsu); 王惠暢(Hwei-Chung Wang); 王仲興(Chung-Hsing Wang); (Chia-Lin Chang); 邱昌芳(Chang-Fang Chiu); 李鳳琴(Hong-Zin Lee); 蔡佳紋(Chia-Wen Tsai); 包大 (Da-Tian Bau)* |
| 亞洲大學 |
2009-02 |
Lung Cancer Susceptibility and Genetic Polymorphisms of Exo1 Gene in Taiwan
|
Hsu, NY (Hsu, Nan-Yung); Wang, HC (Wang, Hwei-Chung); Wang, CH (Wang, Chung-Hsing); Chiu, CF (Chiu, Chang-Fang); Tseng, HC (Tseng, Hsien-Chang); Liang, SY (Liang, Shiu-Yun); Tsai, CW (Tsai, Chia-Wen); Lin, CC (Lin, Cheng-Chieh); Bau, DT (Bau, Da-Tian) |
| 中國醫藥大學 |
2009-02 |
Lung Cancer Susceptibility and Genetic Polymorphisms of EXO1 Gene in Taiwan
|
許南榮(Nan-Yung Hsu);王惠暢(Hwei-Chung Wang);王仲興(Chung-Hsing Wang);邱昌芳(Chang-Fang Chiu);曾憲彰(Hsien-Chang Tseng);梁雲(Shiu-Yun Liang);蔡佳紋(Chia-Wen Tsai);林正介(Cheng-Chieh Lin);包大靝(Da-Tian Bau)* |
| 國立成功大學 |
2009-07-01 |
Lung Cancer Susceptibility and Prognosis Associated With Polymorphisms in the Nonhomologous End-joining Pathway Genes
|
Tseng, Ruo-Chia; Hsieh, Feng-Jen; Shih, Chuen-Ming; Hsu, Han-Shui; Chen, Chih-Yi; Wang, Yi-Ching |
| 中國醫藥大學 |
2009-06 |
Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study
|
曾若嘉(RUo-Chia Tseng); (Feng-Jen Hsieh); 施純明(Chuen-Ming Shih); (Han-Sui Hus); 陳志毅(Chih-Yi Chen); 王憶卿(Yi-Ching Wang)* |
| 國立臺灣大學 |
2008-08 |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu, Jenn-Yu; Shang-GinWu; Chih-HsinYang; Gow, Chien-Hung; Chang, Yih-Leong |
| 臺大學術典藏 |
2018-09-10T07:05:53Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu, J.-Y.; Wu, S.-G.; Yang, C.-H.; Gow, C.-H.; Chang, Y.-L.; Yu, C.-J.; Shin, J.-Y.; Yang, P.-C.; YIH-LEONG CHANG; CHONG-JEN YU; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-03-06T05:26:31Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; YIH-LEONG CHANG; Yu C.-J.; Shin J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-07T06:56:45Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.;Wu S.-G.;Yang C.-H.;Gow C.-H.;Yih-Leong Chang;Yu C.-J.;Shin J.-Y.;Yang P.-C.; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; YIH-LEONG CHANG; Yu C.-J.; Shin J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:23Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Yang P.-C.;Shin J.-Y;Yu C.-J;Chang Y.-L;Gow C.-H;Chih-Hsin Yang;Wu S.-G;Wu J.-Y; Wu J.-Y; Wu S.-G; CHIH-HSIN YANG; Gow C.-H; Chang Y.-L; Yu C.-J; Shin J.-Y; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T08:25:31Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.; SHANG-GIN WU; Yang C.-H.; Gow C.-H.; Chang Y.-L.; Yu C.-J.; Shin J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:34:34Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.;Wu S.-G.;Yang C.-H.;Gow C.-H.;Chang Y.-L.;Yu C.-J.;Shin J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; Chang Y.-L.; Yu C.-J.; Shin J.-Y.; PAN-CHYR YANG |
| 臺大學術典藏 |
2022-06-27T07:06:21Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; Chang Y.-L.; CHONG-JEN YU; Shin J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:35:36Z |
Lung cancer: Diagnosis and staging
|
Lam W.K.;Pan-Chyr Yang; Lam W.K.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-05-26T09:27:06Z |
Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1
|
Chmielecki J; Lin Y.-L; Pan Y; Wang L; De Stanchina E; Shien K; Aoe K; Toyooka S; Kiura K; Fernandez-Cuesta L; Fidias P; CHIH-HSIN YANG; Miller V.A; Riely G.J; Kris M.G; Engelman J.A; Vnencak-Jones C.L; Dias-Santagata D; Ladanyi M; Pao W.; Pao W.;Ladanyi M;Dias-Santagata D;Vnencak-Jones C.L;Engelman J.A;Kris M.G;Riely G.J;Miller V.A;Chih-Hsin Yang;Fidias P;Fernandez-Cuesta L;Kiura K;Toyooka S;Aoe K;Shien K;De Stanchina E;Wang L;Pan Y;Lin Y.-L;Chmielecki J;Moran T;Arcila M.E;Sequist L.V;Ohashi K; Ohashi K; Sequist L.V; Moran T; Arcila M.E |
